About Us | Contact Us
February 5, 2012 2:28 AM EST
Updated: Feb 22, 2010 12:21 PM EST  
Market Commentary

IPOs

Sal Morreale    310-282-6500
 
Anthra Pharmaceuticals
RATING: F/S
SYMBOL: ANTH
EXPECTED RANGE($): 13-15
BUSINESS: Developing anti-inflammatory therapies for acute coronary syndrome and lupus.

NUMBER OF SHARES(MIL): 4.61
UNDERWRITER: DBAB, PIPR, COWN, MERI
Sprott Physical Gold Trust
RATING: F
SYMBOL: PHYS
EXPECTED RANGE($): 10-11
BUSINESS:  Expected to hold 97% of assets in physical gold bullion Delivery bar form.

NUMBER OF SHARES(MIL): 75M
UNDERWRITER: MSCO & RBCM, HSBC

5 Stars = Up 3+

4 Stars = Up 1-3

3 Stars = Up 1/2 - 1

2 Stars = Up 1/4 - 1/2

1 Star = Up 1/4

 

Disclaimer: Prepared by staff of Cantor Fitzgerald & Co. ("Cantor") and is for information purposes only. It is not intended to form the basis of any investment decision, should not be considered a recommendation by Cantor or any other person and does not constitute an offer or solicitation with respect to the purchase or sale of any investment nor is it a confirmation of terms. Any calculations and valuations presented herein are intended as a basis for discussion. Sources of information are believed to be reliable but Cantor makes no representation and gives no warranty that the information contained herein is accurate or complete. Any opinions or estimates given may change. Cantor undertakes no obligation to provide recipients with any additional information or any update to or correction of the information contained herein. This material is intended solely for institutional investors and investors who Cantor reasonably believes are institutional investors. Cantor, its officers, employees, affiliates and partners shall not be liable to any person in any way whatsoever for any losses, costs or claims howsoever arising from any inaccuracies or omissions in the information contained herein or any reliance on that information. Cantor may have positions in financial instruments mentioned, may have acquired such positions at prices no longer available, and may have interests different or adverse to your interests. No liability is accepted by Cantor for any loss that may arise from any use of the information contained herein or derived here from. This product may not be reproduced or redistributed outside the recipient's organization. Sources: Cantor Fitzgerald & Co., Reuters, Bloomberg, CNBC, Dow Jones, Marketwatch, Trade-Alert, and the Wall Street Journal.